A multivalent polyomavirus vaccine elicits durable neutralizing antibody responses in macaques.

[1]  B. Meiser,et al.  Polyomavirus exerts detrimental effects on renal function in patients after lung transplantation. , 2021, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[2]  S. Kremer,et al.  Inadequate Immune Humoral Response against JC Virus in Progressive Multifocal Leukoencephalopathy Non-Survivors , 2020, Viruses.

[3]  D. Reich,et al.  Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease , 2020, Nature Reviews Neurology.

[4]  D. Marx,et al.  Intravenous immunoglobulin as a preventive strategy against BK virus viremia and BKV‐associated nephropathy in kidney transplant recipients—Results from a proof‐of‐concept study , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  U. Liebert,et al.  Persistent BK Polyomavirus Viruria Is Associated with Accumulation of VP1 Mutations and Neutralization Escape , 2020, Viruses.

[6]  M. Platt,et al.  Rhesus macaques as a tractable physiological model of human ageing , 2020, bioRxiv.

[7]  H. Hirsch,et al.  Early fulminant BK polyomavirus-associated nephropathy in two kidney transplant patients with low neutralizing antibody titers receiving allografts from the same donor , 2020, Virology Journal.

[8]  M. Stedman,et al.  Impact of Pre-Transplant Donor BK Viruria in Kidney Transplant Recipients. , 2019, The Journal of infectious diseases.

[9]  M. Feltkamp,et al.  Source and Relevance of the BK Polyomavirus Genotype for Infection After Kidney Transplantation , 2019, Open forum infectious diseases.

[10]  D. Lowy,et al.  Explanations for the high potency of HPV prophylactic vaccines , 2018, Vaccine.

[11]  P. Meltzer,et al.  Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution. , 2018, Cell host & microbe.

[12]  Mitchell Ho,et al.  Infectious Entry and Neutralization of Pathogenic JC Polyomaviruses. , 2017, Cell reports.

[13]  R. Porcher,et al.  Neutralizing Antibody-Mediated Response and Risk of BK Virus-Associated Nephropathy. , 2017, Journal of the American Society of Nephrology : JASN.

[14]  A. Kistler,et al.  Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients , 2017, Transplantation.

[15]  S. Linnenweber-Held,et al.  Viral Origin, Clinical Course, and Renal Outcomes in Patients With BK Virus Infection After Living-Donor Renal Transplantation , 2016, Transplantation.

[16]  F. Tinti,et al.  Different behaviour of BK-virus infection in liver transplant recipients. , 2016, World journal of gastroenterology.

[17]  A. Lazzarin,et al.  JC polyomavirus mutants escape antibody-mediated neutralization , 2015, Science Translational Medicine.

[18]  L. Inker,et al.  BK Virus Nephropathy in Heart Transplant Recipients. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  S. Linnenweber-Held,et al.  Donor origin of BKV replication after kidney transplantation. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[20]  M. Feltkamp,et al.  Different Serologic Behavior of MCPyV, TSPyV, HPyV6, HPyV7 and HPyV9 Polyomaviruses Found on the Skin , 2013, PloS one.

[21]  C. Buck,et al.  BK Polyomavirus Genotypes Represent Distinct Serotypes with Distinct Entry Tropism , 2013, Journal of Virology.

[22]  J. Markmann,et al.  Historical overview of transplantation. , 2013, Cold Spring Harbor perspectives in medicine.

[23]  Christopher P. Johnson,et al.  Donor and Recipient BKV-Specific IgG Antibody and Posttransplantation BKV Infection: A Prospective Single-Center Study , 2013, Transplantation.

[24]  R. Cavallo,et al.  Polyomavirus-associated nephropathy. , 2012, World journal of transplantation.

[25]  L. Groome,et al.  Dynamics of pregnancy‐associated polyomavirus urinary excretion: A prospective longitudinal study , 2012, Journal of medical virology.

[26]  C. Bratton,et al.  Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[27]  D. Brennan,et al.  Neutralization Serotyping of BK Polyomavirus Infection in Kidney Transplant Recipients , 2012, PLoS pathogens.

[28]  J. Carulli,et al.  Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity. , 2011, The Journal of infectious diseases.

[29]  E. Major,et al.  Inhibitory interactions between BK and JC virus among kidney transplant recipients. , 2011, Journal of the American Society of Nephrology : JASN.

[30]  M. Mihatsch,et al.  Reducing Immunosuppression Preserves Allograft Function in Presumptive and Definitive Polyomavirus‐Associated Nephropathy , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[31]  C. Buck,et al.  Characterization of monoclonal antibodies specific for the Merkel cell polyomavirus capsid. , 2010, Virology.

[32]  Spencer T. Martin,et al.  Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[33]  SUPPORTING TABLES,et al.  KDIGO clinical practice guideline for the care of kidney transplant recipients. , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[34]  J. Becker,et al.  Quantitation of Human Seroresponsiveness to Merkel Cell Polyomavirus , 2009, PLoS pathogens.

[35]  J. Schold,et al.  Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States , 2009, Transplant international : official journal of the European Society for Organ Transplantation.

[36]  K. Abbott,et al.  An OPTN Analysis of National Registry Data on Treatment of BK Virus Allograft Nephropathy in the United States , 2009, Transplantation.

[37]  R. Garcea,et al.  Seroepidemiology of Human Polyomaviruses , 2009, PLoS pathogens.

[38]  F. Rehman,et al.  Intravenous immunoglobulin as rescue therapy for BK virus nephropathy , 2009, Pediatric transplantation.

[39]  S. Sunyaev,et al.  Adaptive Mutations in the JC Virus Protein Capsid Are Associated with Progressive Multifocal Leukoencephalopathy (PML) , 2009, PLoS genetics.

[40]  C. Mengelle,et al.  Leflunomide treatment for polyomavirus BK‐associated nephropathy after kidney transplantation , 2007, Transplant international : official journal of the European Society for Organ Transplantation.

[41]  Qin Chen,et al.  Age-Related Urinary Excretion of BK Polyomavirus by Nonimmunocompromised Individuals , 2006, Journal of Clinical Microbiology.

[42]  Xin Dang,et al.  A granule cell neuron-associated JC virus variant has a unique deletion in the VP1 gene. , 2006, The Journal of general virology.

[43]  J. Jordan,et al.  Treatment of Renal Allograft Polyoma BK Virus Infection with Leflunomide , 2006, Transplantation.

[44]  F. Rehman,et al.  Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients. , 2006, Transplantation.

[45]  M. Schnitzler,et al.  Donor Origin of BK Virus in Renal Transplantation and Role of HLA C7 in Susceptibility to Sustained BK Viremia , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[46]  L. Naesens,et al.  Adjuvant Low‐Dose Cidofovir Therapy for BK Polyomavirus Interstitial Nephritis in Renal Transplant Recipients , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[47]  M. Suthanthiran,et al.  Polyomavirus-Associated Nephropathy in Renal Transplantation: Interdisciplinary Analyses and Recommendations , 2005, Transplantation.

[48]  Kwok-Hung Chan,et al.  Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  L. Xing,et al.  Characterization of self-assembled virus-like particles of human polyomavirus BK generated by recombinant baculoviruses. , 2003, Virology.

[50]  A. Clarkson,et al.  BK transplant nephropathy successfully treated with cidofovir. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[51]  K. Shah,et al.  Serological Cross-Reactivities between Antibodies to Simian Virus 40, BK Virus, and JC Virus Assessed by Virus-Like-Particle-Based Enzyme Immunoassays , 2003, Clinical Diagnostic Laboratory Immunology.

[52]  A. Vats,et al.  Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults1 , 2003, Transplantation.

[53]  A. Zvirbliene,et al.  Generation of Recombinant Virus-Like Particles of Human and Non-Human Polyomaviruses in Yeast Saccharomyces cerevisiae , 2003, Intervirology.

[54]  T. Klimkait,et al.  Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. , 2002, The New England journal of medicine.

[55]  W. Knowles,et al.  Expression and antigenic characterization of the major capsid proteins of human polyomaviruses BK and JC in Saccharomyces cerevisiae. , 2002, Journal of virological methods.

[56]  P. Coursaget,et al.  Gene transfer using human polyomavirus BK virus-like particles expressed in insect cells. , 2001, The Journal of general virology.

[57]  C. Ryschkewitsch,et al.  Genotypes of JC virus in East, Central and Southwest Europe. , 2001, The Journal of general virology.

[58]  F. Gudat,et al.  BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[59]  H. Petry,et al.  Molecular Cloning and Expression of Major Structural Protein VP1 of the Human Polyomavirus JC Virus: Formation of Virus-Like Particles Useful for Immunological and Therapeutic Studies , 1999, Journal of Virology.

[60]  F. Madoré,et al.  Determinants of late allograft nephrectomy. , 1995, Clinical nephrology.

[61]  B. Kiberd,et al.  The fate of the failed renal transplant. , 1995, Transplantation.

[62]  B. Padgett,et al.  JC virus, a human polyomavirus associated with progressive multifocal leukoencephalopathy: additional biological characteristics and antigenic relationships , 1977, Infection and immunity.

[63]  T. Hseu,et al.  The major capsid protein, VP1, of human JC virus expressed in Escherichia coli is able to self-assemble into a capsid-like particle and deliver exogenous DNA into human kidney cells. , 1999, The Journal of general virology.

[64]  N. Nathanson,et al.  Human exposure to SV40: review and comment. , 1976, American journal of epidemiology.